Maximus (NYSE:MMS) Reaches New 12-Month Low – Time to Sell?

Maximus, Inc. (NYSE:MMSGet Free Report)’s stock price hit a new 52-week low on Monday . The stock traded as low as $71.60 and last traded at $71.65, with a volume of 161550 shares. The stock had previously closed at $72.70.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.

Read Our Latest Stock Report on MMS

Maximus Stock Down 1.9 %

The firm has a market cap of $4.30 billion, a PE ratio of 14.54 and a beta of 0.73. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The firm’s 50-day moving average price is $84.71 and its two-hundred day moving average price is $87.14.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.68%. Maximus’s dividend payout ratio is presently 24.00%.

Insider Transactions at Maximus

In related news, insider Michelle F. Link sold 1,363 shares of the company’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the sale, the insider now owns 6,567 shares in the company, valued at $607,841.52. This represents a 17.19 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.40% of the company’s stock.

Institutional Trading of Maximus

Several institutional investors and hedge funds have recently bought and sold shares of the business. Inspire Advisors LLC raised its position in Maximus by 1.4% in the 2nd quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider’s stock valued at $751,000 after purchasing an additional 121 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Maximus by 4.5% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock valued at $272,000 after buying an additional 136 shares during the period. Petrus Trust Company LTA increased its stake in Maximus by 2.7% in the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock valued at $660,000 after buying an additional 185 shares during the period. WR Wealth Planners LLC increased its stake in Maximus by 4.6% in the 2nd quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider’s stock valued at $388,000 after buying an additional 198 shares during the period. Finally, GAMMA Investing LLC increased its stake in Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after buying an additional 238 shares during the period. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Company Profile

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.